Pause
Top Energy and Commerce Committee Ranking Members urge Congress to act;
“We have a very serious problem from CRE, a ‘nightmare bacteria.’”
-Centers for Disease Control and Prevention (CDC) Director, Thomas Frieden
Read More >>
Antibiotic resistant infections “...should be ranked alongside terrorism and climate change on the list of critical risks to the nation.”
England’s Chief Medical Officer, Dr. Sally Davies
Read More >>
Microbion,
U Penn & UCSF awarded $2.5M DOD grant.
The U.S. Department of Defense has awarded $2.5 million to support Phase 2 human clinical trials for treatment of orthopedic device-related infections.
Read More >>
NIH superbug outbreak kills 11
Deadly outbreaks of antibiotic-resistant bacteria sparks international concern.
Read More >>
New Research: Microbial biofilms adapt & survive.
Microbial biofilms are an adaptation to various environmental stresses — they have allowed bacteria to thrive in environments of extreme temperature, chemistry, and limited nutrients for over three billion years.
Read More >>
Welcome to Microbion
Microbion is a pioneer in developing innovative, environmentally responsible products that address the issue of biofilm control, both in health and in industry. Products currently in development include antimicrobial drugs that can overcome “superbugs” such as MRSA and carbapenem resistant Gram-negative bacteria, as well as products to protect surgically implanted medical devices from microbial contamination.
For more infomation regarding our company please review: